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The highly selective capture of phosphopeptides from proteolytic digests is a great challenge
for the identification of phosphoproteins by mass spectrometry. In this work, the zirconium
phosphonate-modified magnetic Fe3O4/SiO2 core/shell nanoparticles have been synthesized
and successfully applied for the selective capture of phosphopeptides from complex tryptic
digests of proteins before the analysis of MALDI-TOF mass spectrometry with the desired
convenience of sample handling. The ratio of magnetic nanoparticle to protein and the
incubation time for capturing phosphopeptides from complex proteolytic digests were investi-
gated, and the optimized nanoparticle-to-protein ratio and incubation time were between 15:1 to
30:1 and 30 min, respectively. The excellent detection limit of 0.5 fmol -casein has been achieved
by MALDI-TOF mass spectrometry with the specific capture of zirconium phosphonate-modified
magnetic Fe3O4 nanoparticles. The great specificity of zirconium phosphonate-modified
magnetic Fe3O4 nanoparticles to phosphopeptides was demonstrated by the selective capture
of phosphopeptides from a complex tryptic digest of the mixture of -casein and bovine serum
albumin at molar ratio of 1 to 100 in MALDI-TOF-MS analysis. An application of the magnetic
nanoparticles to selective capture phosphopeptides from a tryptic digest of mouse liver lysate
was further carried out by combining with nano-LC-MS/MS and MS/MS/MS analyses, and
a total of 194 unique phosphopeptides were successfully identified. (J Am Soc Mass
Spectrom 2008, 19, 1176 –1186) © 2008 American Society for Mass SpectrometryPost-translational modifications of proteins controlmany biological processes. The reversible phos-phorylation of proteins is recognized as an essen-
tial post-translational modification regulating cell sig-
naling and ultimately functions of biological systems
[1]. The comprehensive understanding of biological
processes requires the characterization of protein phos-
phorylation at molecular level. Mass spectrometry is a
fundamental tool for detecting and mapping the phos-
phoryl modifications of proteins [2–5]. However, due to
the minimal amount of phosphorylation found on pro-
teins and the serious ion suppression phenomenon
resulting from the proteolytic complexity [6], selective
capture of phosphopeptides from complex proteolytic
products has been remaining quite a challenge in the
field of proteomics.
Up to now, a variety of approaches have been devel-
oped for selective determination of phosphopeptides and
Address reprint requests to Dr. Hanfa Zou, National Chromatographic R
and R Center, Dalian Institute of Chemical Physics, Chinese Academy of
Sciences, Dalian 116023. China. E-mail: hanfazou@dicp.ac.cn Or to Dr.
Ren’an Wu, National Chromatographic R and R Center, Dalian Institute of
Chemical Physics, Chinese Academy of Sciences, Dalian 116023. China.
E-mail: wurenan@dicp.ac.cn
© 2008 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/08/$32.00
doi:10.1016/j.jasms.2008.04.027thus improve the detection sensitivity of mass spectrom-
etry, such as chemical derivatization [7–9], immunopre-
cipitation [10, 11], strong ion-exchange [12, 13], and metal
affinity technique [14 –24]. Among these, the metal affinity
technique using immobilized metal ions or metal oxides
as the affinity moieties to phosphopeptides was the most
frequently applied method, and has been widely applied
for the selective capture or even purification of phos-
phopeptides via the specific binding between the metal
moieties and the phosphoryl groups of peptides and
proteins. For instance, the immobilized metal ions of Fe3,
Ga3, and Zr4  on chromatographic adsorbents showed
the specific binding characteristics to capture phos-
phopeptides [20, 23, 24], and the titanium dioxide (TiO2)
and zirconium dioxide (ZrO2) demonstrated the binding
specificity to phosphopeptides of the complex proteolytic
digests via the bidentate interactions [17–19].
Magnetic nanoparticles have been extensively ap-
plied in chemistry, biochemistry, biology, and medi-
cine, such as drug carriers, bioseparation, sensors, and
enzyme immobilization [25–28] because of the great
convenience of operations by applying a magnetic field
and along with the distinct features resulting from the
high surface-to-volume ratio [29]. In phosphoproteome,
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the selective capture and/or enrichment of phos-
phopeptides from the complex proteolytic digests by
using the metal affinity technique for mass spectrome-
try. For example, Chen et al. [17, 18] used the TiO2 and
ZrO2-coated iron oxide magnetic nanoparticles as the
effective affinity probes for the selective concentration
of phosphopeptides from the tryptic protein digests in
MALDI-TOF MS with a low-femtomole limit of detec-
tion; Tan et al. [30] directly employed the TiO2-modified
magnetic nanoparticles on MALDI targets, which was
also demonstrated the specific capture and confident
detection of phosphopeptides in MALDI-TOF-MS.
Recently, a new method for the specific trapping of
phosphopeptides from the proteolytic digests was de-
veloped using the Zr4-IMAC adsorbents, which
showed higher specificity for phosphopeptides com-
pared with ZrO2 and TiO2 beads [15, 19, 23]. Here, the
zirconium-phosphate (Zr4-PO3)-modified magnetic
Fe3O4/SiO2 (core/shell) nanoparticles were synthesized
for highly selective capture of phosphopeptides from
protein digests. The synthesized magnetic nanoparticles
were first evaluated with tryptic digests of ovalbumin and
- and -caseins, and then were further applied for the
analysis of phosphopeptides with the tryptic digest of a
mouse liver lysate for the phosphoproteome analysis.
Experimental
Materials and Reagents
-Casein and -casein (from bovine milk), trypsin, bovine
serum albumin (BSA), 2,5-dihydroxybenzoic acid (2,5-
DHB), zirconium oxychloride (ZrOCl2 · 8H2O), tetrae-
thoxysilane (TEOS), 2,4,6-collidine, and 3-aminopropyl-
triethoxysilane (APTES) were purchased from Sigma-
Aldrich (St. Louis, MO). Urea, ammonium bicarbonate,
dithiothreitol (DTT), and iodoacetamide (IAA) were
purchased from BioRad (Hercules, CA). Iron (III) chlo-
ride hexahydrate (FeCl3 · 6H2O), iron (II) chloride tetra-
hydrate (FeCl2 · 4H2O), ammonium hydroxide, and
phosphorus oxychloride (POCl3) were obtained from
Tianjin Chemical Plant (Tianjin, China). Acetonitrile,
ethanol and trifluoroacetic acid (TFA) were purchased
from Merck (Darmstadt, Germany). Water used in all
experiments was doubly distilled and purified by a
Milli-Q system (Millipore, Milford, MA).
Synthesis of Fe3O4 Magnetic Nanoparticles
The Fe3O4 magnetic nanoparticles were synthesized
using a literature procedure [17] with certain small
modifications. Briefly, FeCl2 · 4H2O (2.0 g) and
FeCl3 · 6H2O (5.4 g) were first dissolved in a 2 M
hydrochloric acid solution (25 mL), which was then
sufficiently degassed with a nitrogen stream. After that,
a 25.0% (vol/vol) ammonium hydroxide solution (30
mL) was added to the solution for a 30 min reaction at
60 °C with vigorous stirring under a nitrogen atmo-sphere. After cooling to ambient temperature, the re-
sultant magnetic nanoparticles were attracted at the
bottom by a magnet. Followed by the rinse with suffi-
cient water for three times, the magnetic nanoparticles
were finally resuspended in 50 mL water to give a
suspension of ca. 40 mg/mL of magnetic nanoparticle
in water.
Preparation of SiO2-Shell on Fe3O4 Magnetic
Nanoparticles
The above-obtained Fe3O4 magnetic nanoparticles (40
mg/mL, 5 mL) were washed twice with ethanol, and
resuspended in ethanol (80 mL) with 1 h sonication.
Followed by a sequential addition of ammonia (25%,
8.95 mL), water (7.5 mL), and TEOS (1.0 mL), the
resulting mixture was stirred vigorously for 2 h on a
water bath at 40 °C. The resultant magnetic Fe3O4/SiO2
core-shell nanoparticles were then rinsed with ethanol
(30 mL) three times and resuspended in ethanol (30
mL), and subsequently followed by a 12 h reflux at
60 °C to strengthen the Si-O-Fe bonds. The above proce-
dures were repeated once more to ensure the sufficient
cover of SiO2 shell on Fe3O4 magnetic nanoparticles.
Functionalization of Magnetic Fe3O4/SiO2
Core/Shell Nanoparticles
The above produced Fe3O4/SiO2 core/shell magnetic
nanoparticles were dried under vacuum at 60 °C for
12 h and dispersed in dry toluene (45 mL) with sonica-
tion. Followed by an addition of APTES (1.5 mL), the
mixture was refluxed at 110 °C for 12 h under a nitrogen
atmosphere. After cooled to ambient temperature, the
resultant nanoparticles were washed with dry toluene,
water and ethanol twice, respectively. With a further
drying process in a vacuum oven at room temperature,
the dried aminopropyl-modified magnetic nanopar-
ticles were incubated in an anhydrous acetonitrile solu-
tion (50 mL) containing 40 mM POCl3 and 40 mM
2,4,6-collidine at ambient temperature for 12 h. After
rinsing with ACN and water, respectively, the resultant
phosphonate-modified nanoparticles were incubated in
a 50 mM ZrOCl2 solution with gentle stirring overnight
for the loading of Zr4 cations. Finally, the prepared
zirconium-phosphonate-modified nanoparticles were
rinsed with deionized water to remove the nonspecifi-
cally adsorbed Zr4 cations, and dried under vacuum at
30 °C for 12 h.
Tryptic Digestion of Proteins
-Casein and -casein (1 mg) were respectively dis-
solved in a 1 mL of ammonium bicarbonate buffer (50
mM, pH 8.2), and digested at 37 °C for 16 h with trypsin
at the ratio of enzyme-to-substrate of 1:40 (wt/wt). BSA
(6.6 mg) and ovalbumin (4 mg) were, respectively,
dissolved in 1 mL denaturing buffer containing 8 M
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addition of 20 L of DTT (50 mM), the mixtures were
incubated at 60 °C for 1 h to reduce the disulfide bonds
of proteins; subsequently, 40 L of IAA (50 mM) was
added and the mixtures were then incubated at room
temperature in dark for 30 min; finally, the mixtures
were diluted 10-fold with 50 mM ammonium bicarbon-
ate buffer (pH 8.2) and digested at 37°C for 16 h with
trypsin at the ratio of enzyme-to-substrate of 1:40
(wt/wt). The proteins from the mouse liver were
obtained according to the procedure described in a
literature [4], and the Bradford protein assay was used
to quantify the concentration of the extracted proteins.
The tryptic digestion of the proteins frommice liver was
as the same as that of BSA. All of the obtained proteo-
lytic digests were stored in a 30 °C freezer before
MALDI-TOF MS analysis.
The Capture of Phosphopeptides Using Zr4-PO3-
modified Fe3O4/SiO2 Magnetic Nanoparticles
Protein digests were diluted with loading buffer (pH
0.85) containing 6% TFA and 80% (vol/vol) ACN. A
protein digest solution (1 pmol, 2 L) was added into a
10 L suspension of ZrPO3-modified magnetic Fe3O4
nanoparticles (15 mg/mL) in loading buffer, and incu-
bated at room temperature for 30 min. After that, the
magnetic nanoparticles were held by a magnet and the
supernatant was removed by Eppendorf pipette, and
then the magnetic nanoparticles were rinsed with 20 L
of loading buffer solutions containing 6% TFA and 80%
(vol/vol) ACN with and without 200 mMNaCl, respec-
tively. After the evaporation of solvent, 5 L of 25
mg/mL 2, 5-DHB solution containing 70% ACN and 1%
H3PO4 were added and mixed homogeneously with
these dried nanoparticles, where the addition of H3PO4
in matrix solution was for the enhancement of phos-
phopeptide signals on MALDI-TOF MS analysis [31].
Finally, a 0.5 L aliquot of the matrix-nanoparticle
suspension was directly deposited on MALDI-target for
MALDI-TOF MS analysis. For phosphoproteome anal-
ysis of mouse liver lysate, the magnetic nanoparticles
(100 L, 15 mg/mL) were incubated with the tryptic
digest of 200 g mouse liver lysate. Then the nanopar-
ticles were rinsed with 200 L of loading buffer solu-
tions containing 0.5% TFA and 80% (vol/vol) ACNwith
and without 200 mM NaCl, respectively. Subsequently,
the trapped phosphopeptides were eluted from the
nanoparticles as followings: (1) by an 80% (vol/vol)
ACN solution containing 6.0% TFA and with 10 min
incubation, and (2) by an NH4OH solution (pH 11.5, 70
L) with a 15 min sonication. By holding the magnetic
nanoparticles with a magnetic field, the eluted super-
natant was respectively collected, lyophilized, and
then redissolved in 4 L of 0.1% formic acid for
nano-LC-MS/MS and MS/MS/MS analysis.Mass Spectrometry
All MALDI-TOF mass spectra were acquired by a
Bruker Autoflex time-of-flight mass spectrometer
(Bruker, Bremen, Germany) equipped with a delayed
ion-extraction device and a 337-nm pulsed nitrogen
laser. The MALDI uses a ground-steel sample target
with 384 spots. The range of laser energy was adjusted
to slightly above the threshold for obtaining good
resolution and signal-to-noise ratio. All measurements
were carried out in linear positive-ion mode with de-
layed ion extraction. The delay time for ion extraction
and the extraction voltage were set at 90 ns and 20 kV,
respectively. Each MS spectrum was acquired by the
accumulation of 30 laser shots.
All nano-LC-MS analyses were performed on a
ThermoFinnegan LTQ linear ion trap mass spectrom-
eter with a nanospray ion source and a Surveyor HPLC
system (ThermoFinnegan, San Jose, CA). The flow rate
of HPLC pump was split to 200 nL/min by a cross for
capillary separation. A bare fused silica capillary (75
m i.d.  120 mm length) was manually pulled to form
a MS emitter tip (ca. 5 m i.d.) at one end, and then was
in-house packed with C18 AQ particles (5 m, 120 Å;
Michrom BioResources, Auburn, CA) using a pneu-
matic packing device. The packed capillary column was
directly coupled to the LTQ mass spectrometer; 0.1%
formic acid in H2O was used as the mobile phase A, and
0.1% formic acid in acetonitrile was used as the mobile
phase B. The LTQ mass spectrometer was operated at
positive ion mode. A voltage of 1.8 kV was applied to
the cross. About 1 L (50 g) of redissolved peptides
was loaded onto a C18 capillary column as sample loop
and separated on the capillary column with a linear
gradient where the mobile phase B was programmed
from 5 to 35% in 75 min. For the detection of phos-
phopeptides, the mass spectrometer was set to perform
a full scan MS followed by three data-dependant
MS/MS (MS2). Subsequently, an MS/MS/MS (MS3)
(spectrum was automatically triggered when the most
three intense peaks from the MS/MS spectrum corre-
sponded to the neutral loss event of 98, 49, and 33  1
Da for the precursor ion with 1, 2, 3 charge states,
respectively.
Database Search and Data Analysis
The peak lists for MS2 and MS3 spectra were generated
from the raw data by Bioworks (Thermo-Electron, Boston,
MA) with parameters: mass range, 600 to 3500; intensity
threshold, 1000; minimum ion count, 10. The MS2 and
MS3 spectra were searched using SEQUEST [32] (ver-
sion 2.7) against a composite database including both
original database and the reversed version of the for-
ward one with parameters: enzyme, trypsin (KR/P);
enzyme limits, fully enzymatic (cleaves at both ends);
precursor-ion mass tolerance, 2 Da; fragment-ion
mass tolerance, 1 Da; missed cleavages, 2; static mod-
ification, Cys (57). For search with MS2 data, the
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and phosphorylated Ser, Thr, and Tyr (80). For search
with MS3 data, besides the parameters for MS2, dy-
namic modifications were also set for water loss on
Ser, Thr (18). The original database is the non-
redundant mouse protein database of the Interna-
tional Protein Index (ipi.MOUSE.3.17.fasta), which in-
cludes 51,446 entries. For the identification of
nonphosphopeptides by MS2, the criteria were set at:
cross-correlation value (Xcorr) 1.9, 2.2, 3.75 for single,
double, triple charges, and Delta Cn 0.1 [33–35]. For
the identification of phosphopeptides by matching the
assigned sequences derived fromMS2 andMS3 data, the
homemade software named APIVASE [36] was used to
validate the identification. With this software, the MS2/
MS3 target-decoy database search approach (or called
MS2/ MS3 approach in short) was applied to identify
the most likely phosphorylation sites via following four
steps: (1) extraction of the valid MS2/MS3 pairs by
removal of the MS2/MS3 pairs with incorrect charge
states, MS3 not triggered, and intensity of the peak
corresponding to neutral loss less than 50% of the base
peak in MS2; (2) performing MS2 and MS3 target-decoy
database search with the valid MS2 and MS3 spectra,
respectively; (3) reassignment of peptide scores in SE-
QUEST output to generate the peptide lists with the
reassigned scores for MS2 and MS3; (4) filtering the
candidate phosphopeptides with new defined parame-
ters (Rank’m, DCn’m, and Xcorr’s) to achieve phos-
phopeptide identification with specific FDR. In this
study, to achieve the false discovery rate (FDR) of 1%,
the following filter criteria were used: Rank’m  1,
DCn’m  0.1, and Xcorr’s  0.5350. The phosphopro-
teins identified by the same phosphopeptide(s) were
grouped, if the group contained more than one phos-
phoprotein then only one was kept according to the
method described by He et al. [37] as all proteins in each
group are highly homologous, generally belonging to
the same superfamily, or just different alternative splic-
ing isoforms. Finally, to investigate the reliability of the
peptide identification, the PhosphoSite (http:\\www.
phosphosite.org) was used to distinguish the known
from novel phosphorylation sites.
Results and Discussion
Characteristics of Zr4-PO3-Modified Magnetic
Fe3O4/SiO2 (Core/Shell) Nanoparticles
To demonstrate the preparation of the Zr4-PO3-modified
magnetic Fe3O4/SiO2 (core/shell) nanoparticles, a syn-
thesis procedure is illustrated in Scheme 1. Briefly, the
magnetic Fe3O4 nanoparticles were first prepared via a
solvothermal method, and coated with a layer of SiO2
generated from the hydrolysis and condensation of
TEOS. Subsequently, the surface silanol groups on the
SiO2 layer were derivatized to aminopropyl groups by
APTES and further transferred to phosphonate groups
by POCl3. Lastly, after the reaction with ZrOCl2, theZr4 cations were immobilized on the phosphonated
magnetic nanoparticles for selective capture of phos-
phopeptides from proteolytic digests due to the coordi-
nation of zirconium ion and the phosphate moieties
from phosphopeptides. The TEM image (Supplemen-
tary Figure 1, which can be found in the electronic
version of this article) of the Zr4-PO3-modified mag-
netic nanoparticles was recorded at a high magnifica-
tion for nanoparticle characterization. The scale bar
represents 50 nm. The obtained nanoparticles were
aggregated, and the estimated average diameter of
nanoparticles was 16 nm.
Enrichment of Phosphopeptides from Trypsin
Digests of Standard Phosphoproteins
To examine the specific selectivity of the prepared
Zr4-PO3-modified magnetic Fe3O4 nanoparticles for
trapping phosphopeptides, the proteolytic digests of
bovine -casein that posses five known phosphoryla-
tion sites have been extensively selected as the test
standard phosphoprotein with detection of MALDI-
TOF mass spectrometry [15, 24, 38]. First, the tryptic
digest of bovine -casein (1 pmol) was incubated with
certain amount (150 g) of Zr4-PO3-modified magnetic
Fe3O4 nanoparticles at room-temperature for 30 min. By
holding the magnetic nanoparticles with a magnet, the
supernatant was removed by a pipette. Followed by a
series of rinsing steps for removing nonphosphorylated
peptides and salts from the nanoparticles, the MALDI
matrix of 2,5-DHB was added and mixed with the
peptide-bound magnetic nanoparticles and deposited
on MALDI target for mass spectrometry analysis. For
comparison, the same amount of the tryptic digest of
-casein (1 pmol) was directly analyzed by MALDI-
TOF MS without the trapping steps by Zr4-PO3-
magnetic nanoparticles. Figure 1a represents the direct
MALDI-TOF mass spectrum of the tryptic digest of
-casein (1 pmol) without the treatment of the nanopar-
ticles, while Figure 1b represents the obtained MALDI-
TOF mass spectrum of the tryptic digest of the same
amount of -casein (1 pmol) after treated by Zr4-PO3-
magnetic nanoparticles. In Figure 1a, the peaks of the
nonphosphorylated peptides and phosphorylated pep-
Zr4+
O-
Fe3O4
o
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Scheme 1. Synthesis of Zr4-PO3-modified magnetic nanoparticles.
TEOS: tetraethoxysilane; APTES: 3-aminopropyl-triethoxysilane.tides arising from the tryptic digest of -casein were all
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where the phosphorylated peptides were marked as 1,
2, and 3 at m/z 2061.94, 2556.93, and 3122.56, respec-
tively; however, the nonphosphorylated peptide peak
at 1384.30 dominates the mass spectrum and lots of
nonphosphopeptides appear in the mass spectrum. In
contrast, Figure 1b shows a much clearer mass spectro-
metric pattern with only four phosphopeptide peaks
from the tryptic digest of -casein after the specific
capture by Zr4-PO3-magnetic nanoparticles. The iden-
tified phosphopeptides in amino acid sequence pattern
were listed in Table 1. One (S50) of the five known
phosphorylation sites (S30, S32, S33, S34, and S50) of
bovine -casein was founded in both phosphopeptides
of 1 (48-FQ[PS]EEQQQTEDELQK-63, m/z 2061.94) and
2 (48-FQ[PS]EEQQQTEDELQDKIHPF-67,m/z 2556.93).
Other four phosphorylation sites of bovine -casein
were identified in phosphopeptide 3 (16-RELEELN-
VPGEIVE[PS]L[PS][PS][PS]EESITR-40, m/z 3122.56). And
3
2 represents the doubly charged ion derived from 3.
As can be seen in Figure 1b, the peak intensities of these
isolated phosphorylated peptides were significantly en-
Figure 1. MALDI-TOF-MS analysis of tryptic digests of
(a) -casein (1 pmol, 2 L) by direct analysis; (b) -casein (1
pmol, 2 L) treated by Zr4-PO3-modified magnetic nanopar-
ticles; (c) -casein (1 pmol, 2 L) mixed with standard phos-
photyrosine (pY) at ratio of 1:1 and subsequently treated by
Zr4-PO3-modified magnetic nanoparticles; (d) analysis of -
casein (1 pmol, 2 L) treated by PO3-magnetic nanoparticle.hanced5-fold. This is because of the elimination of ionsuppression from nonphosphorylated peptides and
salts after the selective capture of phosphopeptides
using the Zr4-PO3-modified magnetic nanoparticles.
Two other standard phosphoproteins (-casein and
ovalbumin) were also used to examine the selectivity of
Zr4-PO3-modified magnetic nanoparticles; the identi-
fied phosphopeptides are listed in Table 1. These results
indicate that the Zr4-PO3-modified magnetic nanopar-
ticles have the specific selectivity for capturing phos-
phopeptides and thus as the promising substrate for
isolation of phosphorylated peptides from a proteolytic
digest mixture to increase the detection sensitivity of
phosphopeptides with the detection of MALDI-TOF
MS.
The above used phosphoproteins of -casein and
-casein all possess phosphorylation sites at serine
residues. To evaluate the capture performance of Zr4-
PO3-modified magnetic nanoparticles towards other
peptides phosphorylated at different amino acid resi-
dues, a singly tyrosine phosphorylated peptide of
RRLIEDAE[PY]AARG (where pY represents phospho-
tyrosine; molecule weight, 1599) was added to a tryptic
digest of -casein at a 1:1 M ratio, and followed by a
trapping process of phosphopeptides by Zr4-PO3-
modified magnetic nanoparticles and the analysis of
MALDI-TOF MS. As shown in Figure 1c, four dominant
peaks representing three phosphoserine peptides from
-casein (1, 2, 3) and one phosphotyrosine peptide
(pY) can be clearly observed. This result indicated that
Zr4-PO3-modified magnetic nanoparticles do posses
the promising ability to selectively trap other types of
phosphopeptides without bias.
To further confirm the interacting moiety of the
prepared Zr4-PO3-magnetic nanoparticles for selec-
tively isolating phosphopeptides, the tryptic digest of
-casein (1 pmol) were also analyzed by MALDI-TOF
mass spectrometry by using PO3-modified magnetic
nanoparticles without loading of zirconium cations.
Figure 1d represents the obtained MALDI mass spec-
trum of the tryptic digest of -casein using the PO3-
modified magnetic nanoparticle instead of the Zr4-
PO3-modified magnetic nanoparticles. As expected, no
any peaks representing the phosphorylated peptides
from -casein was observed. Based on this result, it can
be confirmed that the selective capture of phosphopep-
tides is from the strong specific interaction between the
immobilized zirconium cations and the phosphoryl
groups of phosphopeptides.
Inspired by the satisfactory enrichment of phos-
phopeptides derived from -casein, we further applied
the Zr4-PO3-modified magnetic nanoparticles on the
selective capture of phosphopeptides from the proteo-
lytic digest of ovalbumin, a diphosphorylated protein
containing a disulfide bond. For ovalbumin, the addi-
tion of urea, DTT, and IAA are necessary for denatur-
ing, opening disulfide bond and carbamidomethylating
cysteine groups before tryptic digestion. It is of interest
to investigate the impacts of urea, DTT, and IAA for
tryptic digestion on the selective capture of phos-
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ticles. Figure 2a and b, represent MALDI mass spectra
of the tryptic digest of ovalbumin (1 pmol, 2 L)
before and after phosphopeptide captured by Zr4-
PO3-modified magnetic nanoparticles. By comparing
Fig. 2a and b, it clearly shows that the phosphopeptides
Table 1. Identification of phosphopeptides from -casein, -cas
magnetic Fe3O4 nanoparticles as affinity probes in MALDI-TOF M
Protein No. Amino acid sequenc
-Casein 1 TVDME[PS]TEVF
2 TVD[Mo]ME[PS]TEVF
b
3 EQL[PS]T[PS]EENSK
4 TVDME[PS]TEVFTK
5 TVD[Mo]E[PS]TEVFTK
b
6 EQL[PS]T[PS]EENSKK
7 VPQLEIVPN[PS]AEER
8 YLGEYLIVPN [PS]AEER
9 DIGSE[PS]TEDQAMEDIK
10 DIG[PS]E[PS]TEDQAMEDIK
11 DIG[PS]E[PS]TEDQA[Mo]EDIK
b
12 YKVPQLEIVPN[PS]AEER
13 KKYKVPQLEIVPN[PS]AEERL
14 NTMEHV[PS][PS][PS]EESII[PS]QE
15 VNEL[PS]KDIG[PS]E[PS]TEDQAM
16 Q*MEAE[PS]I[PS] [PS] [PS]EEIVP
17 QMEAE[PS]I[PS][PS][PS]EEIVPNP
18 KEKVNEL[PS]KDIG[PS]E[PS]TEDQ
19 NANEEEYSIG[PS][PS][PS]EE[PS]A
20 NANEEEY[PS]IG[PS][PS][PS]EE[PS
21 KNTMEHV[PS] [PS] [PS]EE[PS]IIS
-Casein 1 FQ[PS]EEQQQTEDELQDK
2 FQ[PS]EEQQQTEDELQDKIHPF
3 RELEELNVPGEIVE[PS]L[PS][PS][P
Ovalbumin O1 EVVG[PS]AEAGVDAASVSEEFR
O2 FDKLPGFGD[PS]IEAQCGTSVNVH
PS: phosphorylated site.
aThe amino acid sequence are cited from Larsen et al. [15] and Kweon
bOxidation on methionine.
cPyroglutamylation on the N-terminal Q*.
Figure 2. MALDI-TOF mass spectra of a tryptic digest of ovalbu-
min (1 pmol, 2 L) (a) by direct analysis; (b) treated by Zr4-PO -3
modified magnetic nanoparticles.at m/z 2090.62 and 2903.46 can be distinctly isolated
from the strong background of nonphosphopeptides
without the loss of peak intensity by Zr4-PO3-modified
magnetic nanoparticles. The amino acid sequences of
detected phosphopeptides of ovalbumin with marked
phosphorylation sites are illustrated in Table 1. It can be
concluded that the use of urea, DTT, and IAA for tryptic
digestion will not impact the specific capture of phos-
phopeptides with Zr4-PO3-modified magnetic nano-
particles. This is a very interesting merit for using
Zr4-PO3-modified magnetic nanoparticles because the
denaturing processes are routinely applied in proteome
analysis.
Effects of Incubation Conditions on Capture
of Phosphopeptide
To evaluate the effect of the amount of Zr4-PO3-
modified magnetic nanoparticles on the specific capture
of phosphopeptides, the Zr4-PO3-modified magnetic
nanoparticle suspensions at different concentrations
with a certain volume were used for isolating phos-
phopeptides and followed by the detection of MALDI-
TOF MS. Figure 3 shows the peak intensities of the
isolated phosphorylated peptides from the tryptic di-
d ovalbumin tryptic digests by using Zr4-PO3-modified
alysis
Number of phosphoryl
groups Measured m/z
1 1237.08
1 1253.11
2 1411.90
1 1466.97
1 1482.61
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1 1660.15
1 1832.70
1 1847.95
2 1927.89
2 1943.89
1 1951.09
1 2080.00
4 2618.93
3 2678.02
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pmol of protein) ranged from 1:1 to 500:1. As shown in
Figure 3, at low ratio of nanoparticle-to-protein of 1:1,
only two dominant peaks (3 and 3
2) representing
multiphosphopeptides from the tryptic digest of -casein
can be observed, whereas other monophosphopeptides
in the tryptic digest could not be detected, possibly due
to stronger chelating interaction between multiphos-
phopeptide and Zr4 cations on nanoparticles than that
for monophosphopeptides, which resulted in the com-
petitive occupation of the Zr4 sites by multiphos-
phopeptides. When the ratio increased to 5:1, the other
two peaks (1 and 2) of monophosphopeptides were
then observed as well as the increase of the peak
intensity of 3 and 3
2. By further increasing the ratio to
10:1, 15:1, the intensities of detectable peaks of phos-
phopeptides were also increased, and 3
2, 1, and 3
reached the summit at the ratio of 15:1 with the ex-
pected highest capacity for phosphopeptides enrich-
ment. After this summit, the peak intensities of 3
2, 1,
and 3 started to decline when the ratio increased to
30:1, while the peak intensity of the monophosphopep-
tides of 2 increased to the summit. Interestingly, when
the ratio kept on increasing to 100:1 and 500:1, the peak
intensities of phosphopeptides then declined. This phe-
nomenon clearly indicated that the phosphopeptides in
digestion solution have not been maximally adsorbed
when the ratio of 15:1 of nanoparticle-to-protein was
less than 15:1. So, the more nanoparticles used, the more
phosphopeptides were adsorbed onto the nanopar-
ticles, and the peak intensities of phosphopeptides were
thus proportionally increased in MALDI-TOF MS.
However, after the ratio of 15:1, the more nanoparticles
used would result in the decrease of the specific con-
centrations of the phosphopeptides adsorbed on the
surface of the nanoparticles and consequently caused
the decrease of the peak intensities of the phosphopep-
tides. Based on the above observation, the ratio of
nanoparticle-to-protein of 15:1 was selected to capture
phosphopeptides from tryptic digests, which corre-
sponded to the concentration of nanoparticle suspen-
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Figure 3. The effect of the ratio of nanoparticle-to-protein ([mg/
mL]/pmol) on signal intensities (averaged, n 3) of phosphopep-
tides from a tryptic digest of -casein (1 pmol, 2 L).sion of 15 mg/mL for final use.Besides the selection of the ratio of nanoparticle-to-
protein, the incubation time for phosphopeptides en-
richment was also examined. Figure 4 displays the
MALDI mass spectra of the phosphopeptides isolated
by Zr4-PO3-modified magnetic nanoparticles with dif-
ferent incubation time ranged from 0.5 min to 60 min.
As seen in Figure 4, four intensive phosphopeptide
peaks can be observed even the incubation time is only
0.5 min, when the incubation process remained longer
than 30 min, the best peak intensity could be achieved,
it can be assumed that the chelating interaction between
the zirconium cations and the phosphoryl groups of
phosphopeptides have achieved equilibrium. These re-
sults indicated that the affinity nanoparticles have the
good selectivity to capture phosphopeptides even in
short interacting time. For obtaining better analysis
results of phosphopeptides, incubation time of 30 min
was selected.
Detection Sensitivity for Phosphopeptides Using
Zr4-PO3-Magnetic Nanoparticles
After going through the same trapping procedure by
using Zr4-PO3-modified magnetic nanoparticles as the
affinity probes to phosphopeptides with MALDI-TOF
MS analysis, the detection sensitivity of phosphopep-
tides on this approach was evaluated by using 5 fmol
and 0.5 fmol of -casein with the ratio of nanoparticle-
to-protein at 15:1 and the incubation time at 30 min. The
resulting MALDI-TOF mass spectra for 5 fmol and 0.5
fmol of -casein were shown in Figure 5a and b,
respectively. It can be seen that the three phosphopep-
tide peaks of 1, 2, and 3 were well detected at these
low femtomole levels by mass spectrometry after the
enrichment of nanoparticles. The signal-to-noise (S/N)
of detected phosphopeptides of 1, 2, and 3 derived
from 5 fmol -casein were 16, 6, and 7, respectively. For
even lower level of 0.5 fmol -casein, these three 1, 2,
and 3 phosphopeptides peaks were still able to be
detected with S/N of ca. 3. This low fmol level was
considered as the detection limit of this approach for
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Figure 4. The effect of the incubation time on peak intensities of
phosphopeptides captured by Zr4-PO- -magnetic Fe O /SiO3 3 4 2
nanoparticles from a tryptic digest of -casein (1 pmol, 2 L).
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other approaches by using TiO2 beads, ZrO2 beads and
Fe3-immobilized affinity chromatography as the affin-
ity probes in conjunction with MALDI-TOFMS analysis
[15, 17, 18, 31]. The lower limit of detection for phos-
phopeptide could be attributed to large surface-to-
volume ratio of the magnetic nanoparticle, which re-
sults in the high loading capacity of Zr4 cations and
consequently large trapping capacity towards phos-
phopeptides of proteolytic digests.
Validating the Selective Capture of
Phosphopeptides from Other Proteolytic Digests
Phosphoproteins are typically at low abundance in real
biological proteins samples. The specific isolation of
phosphopeptides with the interference of a large
amount of nonphosphorylated peptides is an important
technique for phosphoproteome analysis. However,
Fe3-IMAC adsorbents showed not enough specificity
for selective capture of phosphopeptides from a com-
plex peptides mixture. Using Fe3-IMAC to capture
phosphopeptides, Larsen et al. [15] found that the
number of nonphosphopeptide peaks increased signif-
icantly, while the number of detected phosphopeptides
decreased dramatically when the ratio of phosphopro-
teins (-casein, -casein, and ovalbumin) to nonphos-
phoproteins (serum albumin, -lactoglobulin, and car-
bonic anhydrase) in a protein sample decreased to 1:10;
and when the ratio further decreased to 1:50, the peaks
of phosphopeptides could hardly be detected. This
phenomenon was also observed by Zhou et al. [39]. To
examine the performance of Zr4-PO3-modified mag-
netic nanoparticles for selective capturing phosphopep-
Figure 5. MALDI-TOF mass spectra of a tryptic digest of -
casein of (a) 5 fmol, 6 L; and (b) 0.5 fmol, 8 L, treated by
Zr4-PO-3-magnetic Fe3O4/SiO2 nanoparticles, respectively.tides from a complex protein sample, the mixture ofstandard proteins of -casein and BSA was used. Figure 6
displays the obtained MALDI mass spectra of captured
phosphopeptides from the tryptic digest of the mixture
with different molar ratios of 1:0, 1:10, and 1:100 of
-casein to BSA. In Figure 6a, many nonphosphopep-
tides were observed in mass spectrum. However, in
Figure 6c, 20 phosphopeptides including mono- and
multiphosphorylated peptides were clearly detected at
the molar ratio of -casein to BSA of 1:10. Although the
peak intensities of phosphopeptides were decreased
due to the increased interference from nonphosphory-
lated peptides at higher ratio of protein-to-BSA, this
result is still as good as that of -casein without mixed
with BSA, as shown in Figure 6b, where 21 phos-
phopeptides were observed. The identified phos-
phopeptides from -casein, including amino acid se-
quence and phosphorylation sites, are listed in Table 1. By
further decreasing the molar ratio to 1:100, 17 phos-
phopeptides still could be detected with the similar
peak pattern of phosphopeptides with the disappear-
ance of three phosphopeptide the peaks at m/z 1411.90,
1538.31, and 2678.02 as shown in Figure 6d. But, con-
sidering the level of -casein is two orders of magnitude
lower than that of BSA in sample, the specificity of
Zr4-PO3-modified magnetic nanoparticles is good
enough for the selective capture of phosphopeptides.
This could be contributed by the enhanced surface area
of nanoparticles with the increased loading capacity of
Zr4 cations for binding phosphopeptides.
Application of Zr4-PO3-Magnetic Nanoparticles
for Phosphoproteome Analysis of Mouse Liver
To further evaluate the performance for selective cap-
ture of phosphopeptides in real complex biological
samples, Zr4-PO3-magnetic nanoparticles were also
applied to analyze the phosphoproteome of moue liver.
Based on a further investigation on the effect of TFA
content in washing solution, we found that some phos-
phopeptides could be lost when 6% TFA was used in
washing step, which could be avoided by using a
washing solution containing lower TFA content of 0.5%
(see Supplementary Figure 2). Thus, a two-step elution
protocol was applied for eluting the phosphopeptides
from nanoparticles based on the pre-removal of non-
phosphopeptides by the loading solution containing
0.5% TFA. Namely, the eluents were collected by rins-
ing the nanoparticles with the 80% acetonitrile solution
containing 6% TFA (first eluting step) and the NH4OH
solution (second eluting step), respectively. Then, both
collected eluents were analyzed by nano-LC-MS/MS
and MS/MS/MS, respectively, as described in the Ex-
perimental section. The MS2 and MS3 spectra obtained
were searched against database following the proce-
dures described in the Experimental section, and an
automatic validation approach, i.e., MS2/MS3 approach
[36] was used to process these data. Phosphopeptide
identification by matching the assigned sequences de-
rticle
1184 ZHAO ET AL. J Am Soc Mass Spectrom 2008, 19, 1176–1186rived from MS2 and MS3 data were described in the
Experimental section. As a result, the total of 397 unique
peptides including 203 nonphosphorylated peptides
and 194 phosphorylated peptides were successfully
identified. Among the 194 unique phosphorylated pep-
tides, 39 (29 singly phosphorylated and 10 multi phos-
phorylated) were identified in the first eluting step and
155 (21 singly phosphorylated and 134 multi phosphor-
ylated) were identified in the second eluting step, by the
automatic validation approach. The sequences of the iden-
tified phosphopeptides and their Xcorr scores are listed in
Supplemental Table 1. Themajority of these peptides have
very high Xcorr scores. In the first eluting step, the
monophosphopeptides constitute 74.36% of all identi-
fied phosphopeptides, whereas they accounted for only
13.54% in the second eluting step. This might be as-
cribed to that fact the monophosphorylated peptides
are supposed to have lower binding affinities with
Zr4-PO3-magnetic nanoparticles, and nearly eluted by
Figure 6. MALDI-TOF mass spectra of (a) -ca
the mixtures of -casein(1 pmol, 2 L) and BSA a
treated by Zr4-PO3-modified magnetic nanopaloading solution containing 6% TFA. On the other hand,the multiphosphorylated peptides had higher binding
affinities and were eluted in the second step by the
solution of NH4OH, which is beneficial to the analysis
of multiphosphorylated peptides by MS spectrometry
because they could be easily suppressed by the pres-
ence of singly phosphorylated peptides owing to their
poorer ionization efficiency.
Finally, to investigate the reliability of the results,
PhosphoSite (http:\\www.phosphosite.org) was fur-
ther used to distinguish the known from novel phos-
phorylation sites for the mouse liver lysate. For the 194
identified phosphorylated peptides with 318 phosphor-
ylated sites, it was found 88.99% (283 sites) were
identified as the known phosphorylation sites (see
Supplemental Table 1). These results indicated the
phosphopeptides identified both by MS2 and MS3 spec-
tra are of high confidence. These results also showed
that the Zr4-PO3- magnetic nanoparticles do have high
specificity for the capture of phosphopeptides in real
tryptic digest (1 pmol, 2 L) by direct analysis;
ios of (b) 1:0, (c) 1:10, and (d) 1:100, respectively,
s.sein
t ratcomplex biological samples and are of very promising
1185J Am Soc Mass Spectrom 2008, 19, 1176–1186 PHOSPHOPEPTIDE CAPTURE BY MAGNETIC NANOPARTICLESin the purification of phosphopeptides for phosphopro-
teome analysis.
Conclusions
In this work, the zirconium phosphonate-modified
magnetic Fe3O4/SiO2 (core/shell) nanoparticles have
been successfully prepared and applied as the affinity
probes for the specific capture of phosphopeptides from
complex tryptic digests with the detection of MALDI-
TOF mass spectrometry. The affinity interactions be-
tween the zirconium phosphonate-modified magnetic
nanoparticles and the phosphopeptides resulted from
the strong chelating interactions between the zirconium
cations and the phosphoryl groups of phosphopeptides.
The specificity of the Zr4-PO3- magnetic nanoparticles
has been confirmed by the selective capture of phos-
phopeptides from the tryptic digests of standard phos-
phoproteins, and the mixture of standard protein with
BSA at the molar ratio of standard protein-to-BSA up to
1:100. The performance of the magnetic nanoparticles
was also investigated by applying the nanoparticles to a
tryptic digest of a mouse liver lysate, followed by
nano-LC-MS/MS and MS/MS/MS analysis for phos-
phoproteome analysis, which confirmed that the mag-
netic nanoparticles did show their specificity in selec-
tive capture of phosphopeptides even from a complex
real sample. In addition, the isolation procedure of
phosphopeptides from the complex tryptic digests of
proteins was very convenient by applying an extra
magnetic field to hold the Zr4-PO3-magnetic nanopar-
ticles, which significantly reduced the analysis time and
the loss of sample.
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